Stifel Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating, Cuts Target Price to $16

Moomoo NewsNov 6, 2024 08:37 ET · Ratings

Express News | Black Diamond Therapeutics Inc : Stifel Cuts Target Price to $16 From $18

ReutersNov 6, 2024 07:03 ET

Black Diamond Therapeutic Analyst Ratings

BenzingaNov 6, 2024 04:47 ET · Ratings

TD Cowen Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating

Moomoo NewsNov 5, 2024 11:31 ET · Ratings

Strong Buy Rating for Black Diamond Therapeutics Driven by Financial Stability and Promising Clinical Developments

TipRanksNov 5, 2024 10:25 ET · Ratings

Express News | Black Diamond Therapeutics Inc: Clinical Updates of Bdtx-1535 in Egfrm Nsclc and Regulatory Feedback Expected in Q1 2025

ReutersNov 5, 2024 08:02 ET